Skip to main content
Premium Trial:

Request an Annual Quote

Merck Expands GeneGo License to MetaCore to Include All Its Scientists

NEW YORK (GenomeWeb News) – GeneGo yesterday said that German pharma Merck has expanded its license to the company’s MetaCore product to allow all Merck employees to access the software “in perpetuity.”
 
Merck researchers will use the technology in both early discovery and new compound safety testing, GeneGo said.
 
"We see MetaCore as a further step into systems biology, a novel discipline which holds much promise for pharmaceutical research," said Friedrich Rippmann, director of bio- and chemoinformatics at Merck.

Filed under

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.